David Rhodes

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Akashi Therapeutics Inc is a clinical stage biopharmaceutical company based in Cambridge, MA with subsidiaries in the United States. The private company has been granted orphan designation for DMD in both the US and Europe. The American company's mission is to develop treatments for Duchenne muscular dystrophy and other rare pediatric diseases. Akashi is developing a cocktail of medications with the goal of transforming Duchenne from a 100% fatal, aggressive muscle-wasting disease to a chronic, manageable condition. The application of HT-100 to DMD and other fibrotic diseases is based on pioneering work by Dr. Mark Pines at the Volcani Institute. Dosing and new patient enrollment in the phase 1b/2a clinical program have been suspended. The company was founded by leading patient organizations and biotechnology industry veterans and is managed by a seasoned team of drug development experts. The company was founded by Marc B. Blaustein, Thomas C. Wicka.

Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA.

Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA.

CNBC Global CFO Council operates as a business association of chief financial officers. The private company is based in Chicago.

AccentCare, Inc. engages in the provision of home health care services. Its services include personal care services, hospice care, private duty nursing, and care management. The company was founded by Scott Brogi, Robert Prosek, Joseph I. Davis, and Janet M. Biski and is headquartered in Dallas, TX.

Change Healthcare Engagement Solutions, Inc. provides healthcare cost transparency solutions. It offers Healthcare Transparency Index that shows medical procedures with high costs and price variances. The firm’s solutions enable consumers to better understand and utilize their healthcare benefits; make informed healthcare purchasing decisions based on quality, cost, and convenience; and manage out-of-pocket responsibility and realize savings. Its solutions also enable users to engage alerts that show savings opportunities, and help take advantage of company health and wellness programs; educate health plan enrollees; and leverage investment with third-party decision support tools. The company was founded by Christopher Parks in 2007 and is headquartered Nashville, TN.

Culligan International Co. provides water treatment products and services. The firm specializes in water softener & filter, commercial filtration, reverse osmosis, bottled water delivery and water technology. The company was founded by Emmett Joseph Culligan in 1936 and is headquartered in Rosemont, IL.

Guide Therapeutics, Inc. develops biophotonic technology platform for the early detection of disease that leads to cancer. The company was founded by James Dahlman and Cory Sago and is headquartered in Tucker, GA.

Wilco Holdco, Inc. operates as a healthcare company, specializing in outpatient rehabilitation and adjacent healthcare services. The company is headquartered in Bolingbrook, IL.

Visionary Systems, Inc. engages in consumer risk evaluation and decisioning services to facilitate credit granting and target marketing processes. The company was founded by James Eckstein in 1996 and is headquartered in Chicago, IL.

TransUnion Rental Screening Solutions, Inc. provides tenant screening services. It offers applicant-screening products for the property management industry. The firm also provides financial solutions that enable customers to manage risk and capitalize on market opportunities. The company was founded in 2004 and is headquartered in Greenwood Village, CO.

TransUnion Interactive, Inc. provides credit information and information management services. Its online products include credit reports, credit and insurance scores, credit monitoring, debt management tools and identity theft insurance services. The firm operates under the brand name TrueCredit. The company was founded in 1999 and is headquartered in Chicago, IL.

TransUnion Healthcare LLC provides patient access and collections and recovery systems. It offers a series of data solutions designed to provide accuracy and transparency in the revenue cycle process thereby assisting providers in lowering their uncompensated care. The company was founded on December 18, 2009 and is headquartered in Charlotte, NC.

Ned Biosystems, Inc. is a clinical-stage company based in Cambridge, MA. The company is focused on developing cancer treatments with the goal of providing uncommon therapies that help patients achieve "No Evidence of Disease."

Trans Union LLC provides information and risk management solutions to individual consumers and businesses. Its products and solutions include customer credit reporting, marketing and audience segmentation, customer acquisition, fraud and ID management, analytics and consulting, portfolio management, healthcare revenue cycle management, investigations and collections, customer engagement solutions and data breach services. The company was founded in 1968 and is headquartered in Chicago, IL.

Tufts Medical Center, Inc. owns and operates an academic medical center. It provides healthcare services and programs in the areas of allergy, anesthesiology, bariatric surgery, cancer, cardiology, colon and rectal, clinical nutrition, dentistry, dermatology, ENT/otolaryngology, endocrinology, diabetes and metabolism, gastroenterology, general surgery, geriatrics, hematology/oncology, hyperbaric medicine, infectious diseases, maternity, nephrology, neurology, neurosurgery, and nutrition. The firm also offers services in the areas of obstetrics and gynecology, occupational therapy, ophthalmology, orthopedics, otolaryngology, pain management, palliative care, pathology, pediatrics, physical medicine, physical therapy, plastic surgery, psychiatry, pulmonary, radiation oncology, radiology, rheumatology, speech language pathology and audiology, thoracic and transplant surgery, trauma surgery, urology, vascular surgery, wound healing, and weight and wellness. The company was founded in 1796 and is headquartered in Boston, MA.

Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA.

Agilis Biotherapeutics LLC operates as a biotechnology company. It focuses on designing and engineering first-in-class DNA-based therapeutics to improve and save the lives of patients affected by life-threatening or fatal rare diseases for which there are no or limited treatment options. The company was founded in 2013 and is headquartered in Cambridge, MA.

Delix Therapeutics, Inc. is a clinical-stage neuroscience company that focuses on developing novel neuroplasticity-promoting therapeutics to treat neuropsychiatric and neurological disorders. The company's compounds are small molecules that can induce structural and functional neural changes in targeted areas of the brain. Delix is pioneering a new class of fast-acting outpatient pharmacotherapies and advancing through preclinical and clinical development to bring patients FDA-approved, take-home medicines that will serve several unmet needs. The company is headquartered in Palo Alto, CA, and has subsidiaries in the United States. Delix was founded by David E. Olson, Nick Haft, Nicholas Haft, and Paul A. Conley, and Mark Rus has been the CEO of the company since 2021.

Ellodi Pharmaceuticals engages in the provision of pharmaceutical services. It is dedicated to the clinical development of APT-1011, a novel therapy in Phase 3 development for the treatment of Eosinophilic Esophagitis (EoE) spun-out of Adare Pharmaceuticals (Adare). The company is headquartered in the United States.